Abstract:Objective To explore the effect and mechanism of long non-coding RNA HLA complex 11 group (lncRNA HCG11,abb.HCG11) on the malignant biological behavior of HEp-2 laryngeal cancer cells. Methods Through plasmid transfection, HEp-2 cells from human laryngeal squamous cell carcinoma were divided into a HCG11 control group and an overexpression group, with NP69 nasopharyngeal epithelial cells as the normal control. Expression levels of HCG11 in these groups were assessed by quantitative polymerase chain reaction (qPCR). Cellular proliferation was measured via cloning formation assays, migration was monitored using scratch tests, apoptosis was identified through Annexin V/PI staining, and intracellular reactive oxygen species (ROS) levels were quantified with the DCFH-DA fluorescent probe. Mitochondrial structure was visualized under transmission electron microscope, and the protein expressions of PINK1, Parkin, the LC3 II/I ratio, and p62 were determined by Western blot. Results The qPCR results revealed that the expression level of HCG11 in laryngeal cancer cells was lower than that in normal cells, and an HCG11 overexpression model in laryngeal cancer cells was successfully constructed. Compared with the control group, the proliferation, migration, and apoptosis of HEp-2 cells in the HCG11 overexpression group were all inhibited (P<0.05), the intracellular ROS level increased (P<0.05), the mitochondrial morphology inside the cells was damaged, the protein levels of PINK1, Parkin, LC3Ⅱ/LC3Ⅰin the cells increased, while the protein level of p62 decreased (P<0.05). Conclusion The expression of lncRNA HCG11 is downregulated in HEp-2 laryngeal cancer cells. Overexpression of HCG11 can inhibit the proliferation, migration and apoptosis of HEp-2 laryngeal cancer cells. The underlying mechanism may be related to the activation of the PINK1/Parkin signaling pathway, thereby regulating excessive autophagy of intracellular mitochondria.